SREBF1 and neoplasm: The tumor suppressor TIP30 (HTATIP2 or CC3) could inhibit lipid metabolism by the AKT/mTOR signaling pathway, decreasing the expression of SREBP1 and its target genes (SCD and FASN) and thus inhibiting the tumor growth of liver cells (Fig. 2).37